THORATEC CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-11-01: Form 8-K; Period of report 2012-11-01; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-10-11: Form 8-K; Period of report 2012-10-10; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2012-08-01: Form 8-K; Period of report 2012-08-01; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-05-29: Form 8-K; Period of report 2012-05-23; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-11-01 | 8-K | 2012-11-01 | 2.02 Results of Operations and Financial Condition | 2.02 On November 1, 2012, Thoratec Corporation (the “Company”) issued a press release announcing its third quarter ended September 29, 2012 results, the text of which is attached hereto as Exhibit 99.1. | v327173_8k.htm |
| 2012-10-11 | 8-K | 2012-10-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 11, 2012, Thoratec Corporation (the “Company”) issued a press release, which is filed herewith as Exhibit 99.1, announcing that effective October 10, 2012 it has appointed Taylor Harris as Vice President and Chief Financial Officer of the Company. | a12-23634_18k.htm |
| 2012-08-01 | 8-K | 2012-08-01 | 2.02 Results of Operations and Financial Condition | 2.02 On August 1, 2012, Thoratec Corporation (the “Company”) issued a press release announcing its second quarter ended June 30, 2012 results, the text of which is attached hereto as Exhibit 99.1. | v320079_8-k.htm |
| 2012-05-29 | 8-K | 2012-05-23 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Thoratec Corporation (the “Company”) Annual Meeting of Shareholders held on May 23, 2012 (the “Annual Meeting”), the shareholders of the Company voted on the following four proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2012. | a12-12941_18k.htm |
| 2012-05-01 | 8-K | 2012-05-01 | 2.02 Results of Operations and Financial Condition | 2.02 On May 1, 2012, Thoratec Corporation (the “Company”) issued a press release announcing its first quarter ended March 31, 2012 results, the text of which is attached hereto as Exhibit 99.1. | v311362_8k.htm |
| 2012-03-09 | 8-K | 2012-03-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 8, 2012, the Compensation Committee of Thoratec Corporation (the “Company”), approved the Thoratec Corporation Executive Incentive Plan FY2012 (the “Plan”), pursuant to which certain members of management, including the current executive officers, may receive bonuses for 2012. | a12-6845_18k.htm |
| 2012-02-08 | 8-K | 2012-02-08 | 2.02 Results of Operations and Financial Condition | 2.02 On February 8, 2012, Thoratec Corporation (the “Company”) issued a press release announcing its fourth quarter ended December 31, 2011 results, the text of which is attached hereto as Exhibit 99.1. | v301650_8k.htm |
| 2012-01-25 | 8-K | 2012-01-25 | 8.01 Other Events | 8.01 On December 13, 2011, Thoratec Corporation (the “Company”) received a proxy proposal from Oracle Partners, LP (“Oracle”), which requested that the Company engage the services of a nationally recognized investment bank to evaluate strategic alternatives to maximize shareholder value. | a12-3471_18k.htm |
| 2012-01-12 | 8-K | 2012-01-04 | 8.01 Other Events | 8.01 Thoratec Corporation, a California corporation (“Thoratec” or the “Company”), received a Warning Letter from the U.S. Food and Drug Administration (“FDA”) on January 4, 2012. | a12-2665_18k.htm |